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AntagonismWe examined the characteristics of interferon alpha/beta (IFN-α/β) induction after alphavirus or control
Sendai virus (SeV) infection of murine ﬁbroblasts (MEFs). As expected, SeV infection of wild-type (wt) MEFs
resulted in strong dimerization of IRF3 and the production of high levels of IFN-α/β. In contrast, infection of
MEFs with multiple alphaviruses failed to elicit detectable IFN-α/β. In more detailed studies, Sindbis virus
(SINV) infection caused dimerization and nuclear migration of IRF3, but minimal IFN-β promoter activity,
although surprisingly, the infected cells were competent for IFN production by other stimuli early after
infection. A SINV mutant defective in host macromolecular synthesis shutoff induced IFN-α/β in the MEF
cultures dependent upon the activities of the TBK1 IRF3 activating kinase and host pattern recognition
receptors (PRRs) PKR and MDA5 but not RIG-I. These results suggest that wild-type alphaviruses antagonize
IFN induction after IRF3 activation but also may avoid detection by host PRRs early after infection.
© 2009 Elsevier Inc. All rights reserved.Introduction
Data collected using mice deﬁcient in type I interferon (interferon
alpha/beta [IFN-α/β]) responses have shown this innate immune
system to be critical for host survival of infections with many viruses,
including alphaviruses (Ryman et al., 2000; White et al., 2001;
Couderc et al., 2008; Fragkoudis et al., 2007; Gardner et al., 2009). The
IFN-α/β response is induced by interaction of particular virus struc-
tures or replicative intermediates (known as pathogen-associated
molecular patterns [PAMPs]) with host pattern recognition receptors
(PRRs) that initiate signaling cascades within infected cells. However,
virtually nothing is known about the particular PAMPs or host PRRs
involved in IFN-α/β induction by the alphaviruses or how activation
of these pathways differs between alphavirus types. Potential PRRs
include extracellular and endosomal receptors such as toll-like
receptors (TLRs) (Iwasaki and Medzhitov, 2004; Uematsu and Akira,
2008), C-type lectin scavenger receptors (McGreal et al., 2004;
Geijtenbeek and Gringhuis, 2009), and intracellular receptors that
appear to recognize intermediates of RNA virus replication such as
PKR (Jiang et al., 2003; Williams, 2001) and the RIG-I, MDA5 and Lgp2
RNA helicases (Yoneyama et al., 2004; Kang et al., 2002; Kato et al.,ll rights reserved.2006; Venkataraman et al., 2007; Meylan et al., 2006). Potential viral
PAMPs include glycoproteins (C-type lectins; TLR2) and viral ssRNA
(TLR7) or dsRNA (TLR3, PKR, and RIG-I) (Meylan et al., 2006; Uematsu
and Akira, 2008; Geijtenbeek and Gringhuis, 2009; Williams, 2001).
A distinction is generally made between the cell-surface/endoso-
mal PRRs (C-type lectins, TLR3, TLR7 and others) and the cytoplasmic
PRRs (PKR, RIG-I and MDA5) in that the cell-surface PRRs are ex-
pressed only by subsets of dendritic cells (DCs) or macrophages,
whereas cytoplasmic PRRs are expressed by most cells (Meylan and
Tschopp, 2006; Pollara et al., 2005; Uematsu and Akira, 2008). There-
fore, viral induction of IFN-α/β may exhibit cell type speciﬁcity,
depending upon the pathway(s) triggered. Several signaling path-
ways resulting in IFN-α/β induction have been elucidated for the
various PRRs. The canonical induction pathway was originally deﬁned
as dsRNA replicative intermediates in the cytoplasm activating the
IRF3 transcription factor, which is then translocated to the nucleus
where it activates IFN-β gene transcription (Schafer et al., 1998). This
involves detection of viral RNAs by the RIG-I or MDA5 RNA helicases,
followed by recruitment of the IPS-1 adapter molecule and activation
of tank binding kinase 1 (TBK1 also IKKɛ in lymphoid cells), which
may directly phosphorylate IRF3 (Lee and Kim, 2007; Paz et al., 2006;
McWhirter et al., 2004; Fitzgerald et al., 2003). Interestingly, recent
studies indicate that, while MDA5 may interact with dsRNA, RIG-I is
activated by interaction with uncapped RNA molecules containing 5′-
triphosphates (Kang et al., 2002; Gitlin et al., 2006; Pichlmair et al.,
Fig. 1. Interferon production from MEFs after infection with different alphaviruses.
Control and TBK1−/−MEFs were infected with each virus for 1 h at 37 °C at anMOI of 3.
Supernatants were harvested for biological interferon assay at the times indicated. Each
bar represents the average of triplicate samples. Error bars are standard deviations but
are too small to be seen. Some of these data were published previously (Ryman and
Klimstra, 2009).
122 C.W. Burke et al. / Virology 395 (2009) 121–1322006; Hornung et al., 2006). PKR, a dsRNA-binding protein, appears to
augment the induction of IFN-α/β by signaling through the NFκB
pathway and may be a downstream modulator of TLR3 signaling
(Jiang et al., 2003). With the exception of TLR3, TLRs signal through
the canonical TLR pathway including MyD88-IRAK1 adaptor proteins
to activate NFκB and induce the IFN-β promoter. In contrast, TLR3
signals through the TRIF/TRAF6 pathway to activate both NFκB and
TBK1-IRF3 (Honda et al., 2006).
For alphaviruses, it is known that type I IFN is induced in vitro by
infection of some cell types (Grifﬁn, 2001) but that infection of
establishedmurine ﬁbroblast cell lines with the prototypic alphavirus,
Sindbis virus (SINV), does not result in IFN production (Frolova et al.,
2002). This has led to the hypothesis that some alphaviruses anta-
gonize IFN production in vitro by shutoff of host macromolecular
synthesis (Frolova et al., 2002; Aguilar et al., 2007) but the speciﬁc
points of blockage of IFN production have not been delineated. In
contrast with cultured ﬁbroblasts, high levels of serum IFN-α/β are
associated with systemic replication of Sindbis virus (SINV) and
Venezuelan equine encephalitis virus (VEEV) in vivo (Charles et al.,
2001; Klimstra et al., 1999; Ryman et al., 2000, 2002; Gardner et al.,
2008). However, the cell types responsible for its production and the
relationship of induction pathways in vivo to those in cultured cells are
unknown.
Regarding PRRs involved in IFN induction by alphaviruses, one
study concluded that induction of IFN-α/β by Semliki Forest virus
(SFV) in myeloid DC cultures occurred independently of MyD88, but
was dependent upon IRF3 (Hidmark et al., 2005). Furthermore, IFN-α
induction was minimally impaired in MDA5−/− macrophages
infected with SINV, suggesting that this molecule was not vital to
responses against alphaviruses with this cell type (Gitlin et al., 2006).
Aside from these two studies, the alphavirus-expressed PAMPs and
particular PRRs and pathways associated with IFN-α/β induction
remain essentially uncharacterized.
In the current studies, we have evaluated the IFN-α/β induction
characteristics after infection of primarymurine ﬁbroblast (MEF) cells
with SINV, VEEV, eastern equine encephalitis (EEEV) or chikungunya
(CHIKV) viruses. None of the viruses induced substantial IFN-α/β in
the MEFs at any time after infection. In contrast, infection with Sendai
virus (SeV) induced IFN-α/β promoter activity, formation of IRF3
dimers and their nuclear translocation, and production of biological
IFN-α/β by 12 h post-infection (h p.i.). In detailed analyses, wild-type
SINV also induced activation and nuclear translocation of IRF3 and an
increase in its DNA binding but no transcription or protein synthesis
was detected from genes under the control of the IFN-β promoter.
Interestingly, IFN-α/β induction was detected early after infection in
cells co-treated with wt SINV (TR339 strain) and IFN agonists SeV or
poly(I:C), suggesting that the infected cells were competent for IFN
production. When macromolecular shutoff was reduced by use of a
non-cytopathic version of SINV (39nc), IFN-α/β was induced later
after infection, largely dependent upon PKR and MDA5 PRR signaling
through TBK1. Together, these data suggest that wild-type SINV, and
likely other alphaviruses, antagonizes IFN-α/β induction from
infected MEFs through shutoff of host macromolecular synthesis but
also appears to avoid induction prior to the time at which shutoff is
complete.
Results
Wild-type alphaviruses do not trigger IFN-α/β production from infected
MEF cultures
Many previous studies examining IFN-α/β induction by RNA
viruses have usedmurineﬁbroblasts because of the availability ofmice
deﬁcient in speciﬁc components of the IFN-α/β induction pathways
and ease of MEF cell line generation. To test the role of TBK1 in
alphavirus IFN-α/β induction, we began by comparing wild-type (wt)MEFs to those deﬁcient in TBK1. Using a biological IFN-α/β assay we
found that infection of wtMEFs with SeV, used as a positive control for
RIG-I-dependent IFN-α/β induction (Kato et al., 2005; Yoneyama et
al., 2004), resulted in detectable production of IFN-α/β by 12 h p.i.,
whereas in the absence of TBK1, SeV failed to induce detectable IFN-α/
β (Fig. 1), consistent with previous reports (e.g., McWhirter et al.,
2004). Furthermore, the wt MEFs responded to transfection with poly
(I:C), a MDA5/PKR agonist (Gitlin et al., 2006; Diebold et al., 2003)
with production of IFN-α/β (data not shown). These data suggest that
RIG-I andMDA5/PKR virus detection pathways were functional in the
MEF cultures.
In contrast, infection (multiplicity of infection [MOI]=3) of either
wt or TBK1-deﬁcient MEFs with wild-type SINV strain TR339 or the
more human-virulent alphaviruses VEEV, EEEV or CHIKV resulted in
very low (b10 IU/ml) or no detectable IFN-α/β release prior to death
of the cells (between 18 and 32 h p.i.) measured by bioassay (Fig. 1) or
IFN-β ELISA (data not shown). The failure of these cells to produce
IFN-α/βwas generally applicable to multiply passaged MEF-like cells
as conﬁrmed by infection of four other wt C57BL/6-derivedMEF lines,
murine Swiss 3t3 ﬁbroblasts or murine L929 ﬁbroblasts (data not
shown).
Wild-type alphaviruses do not block IRF3 activation or translocation to
the nucleus in infected MEF cultures
In order to determine the mechanism by which the alphaviruses
antagonize IFN-α/β production from infected MEFs, we monitored
cellular responses to virus infection at each sequential step in the IFN-
α/β induction pathway. Constitutively-expressed transcription factor
IRF3 is a master regulator of host antiviral defense activation (Hiscott
et al., 1999, 2007). Upon virus detection, latent IRF3 is phosphorylated
by TBK1 or IKKɛ kinases, causing IRF3 dimerization and translocation
to the nucleus where it binds to the IFN-β promoter and stimulates
transcription of the gene (Weaver et al., 1998; Lee and Kim, 2007;
Taniguchi et al., 2001; Fitzgerald et al., 2003). A number of viruses
antagonize/evade these early steps in the IFN-α/β induction pathway
in order to avoid the IFN-α/β response (Randall and Goodbourn,
2008; Haller et al., 2007).
To determine if the lack of IFN-α/β production from SINV TR339-
infected MEF cultures was due to the failure or inhibition of IRF3
activation, we ﬁrst used native PAGE analysis to examine the diffe-
rential migration of activated IRF3 dimers versus inactive monomers.
We conﬁrmed the formation of activated IRF3 dimers in wild-type
MEFs at 12 h p.i. with SeV and also demonstrated activation in SINV
TR339-infected cells; however, IRF3 dimerization was not detected
after infection of TBK1-deﬁcient MEFs with either SeV or SINV TR339
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in SINV-infected MEFs and is triggered primarily via a TBK1-
dependent detection mechanism. Subcellular fractionation analyses
indicated that translocation of dimerized IRF3 to the nucleus was also
not blocked after infection of wt MEFs with either SeV or SINV TR339
viruses (Fig. 2B). In this assay, staining for tubulin (cytoplasmic
protein) and lamin A/C (nuclear protein) in control samples con-
ﬁrmed that the fractionation was successful.
As a functional measure of IRF3 activation, the DNA-binding
capacity of IRF3 was examined with an oligonucleotide pull-down
assay performed on lysates from SINV TR339 or SeV-infected MEFs
(Fig. 2C). Samples fromwt, but not TBK1-deﬁcient, MEFs infectedwith
either SeV or SINV TR339 resulted in a reproducible increase in IRF3-
DNA binding compared to mock-infected cells, suggesting that some
portion of IRF3 is activated by both viruses via a TBK1-dependent
pathway to bind DNA after infection of MEFs.
These assays give only a measurement of total IRF3 activation in
the cultures and no information regarding the extent of IRF3 acti-
vation within individual cells. To examine the latter, we transfected
wt or TBK1-deﬁcient MEFs with a plasmid expressing an IRF3/GFP
fusion protein (Mibayashi et al., 2007) and evaluated the cytoplas-
mic versus nuclear localization of GFP signal at 8 h p.i. with SINV
TR339 or VEEV to represent the Old and New World alphaviruses,
respectively (Fig. 2D). While anti-alphavirus staining revealed that
virtually all of the cells were infected, those cells that were
successfully transfected with the plasmid were rendered refractory
to alphavirus infection by an IFN-α/β signaling-dependent mecha-
nism. Therefore, we used MEFs derived from IFN-α/β receptor-null
mice (IFNAR−/−) and included in the analyses only those cells
positive for anti-alphavirus staining and expressing IRF3/GFP. As
expected, signiﬁcant nuclear translocation of IRF3/GFP was observed
following SeV infection (pb0.01 versus mock). Similarly, infectionFig. 2. Activation and nuclear translocation of IRF3 after infection of MEFs. (A) Control or
lysates were harvested at 12 h p.i. for native PAGE separation of proteins and Western
described in Materials and methods. Proteins transferred to membranes were stained wi
infected and harvested as in (A) and processed for oligonucleotide pull-down assay and
indicate relative levels of bound IRF3 with values for mock-infected cells set to 1.0. Valu
Control MEFs were transfected with a plasmid encoding an IRF3/GFP fusion protein as de
virus 18 h later at an MOI of 3. At 8 h p.i., appropriate cells were stained for either SINV o
triplicate using ﬂuorescence microscopy for at least 50 cells in which virus proteins and G
seen.with SINV TR339 or VEEV resulted in a signiﬁcant translocation of
IRF3/GFP to the nucleus (pb0.01 for each virus versus mock). Under
these conditions, VEEV appeared to cause more consistent nuclear
translocation in infected cells, similar to SeV. Direct antibody stain-
ing of nucleus-translocated IRF3 could not be achieved in the MEF
culture system; however, we conﬁrmed the IRF3/GFP plasmid re-
sults by costaining for IRF3 and alphavirus structural protein in
infected 293 human kidney cells followed by confocal microscopy
(data not shown).
Taken together, these data suggest that at least some of the Old and
New World alphaviruses behave similarly in that they do not
antagonize IFN-α/β inductive signaling pathways upstream of the
nuclear translocation of IRF3 dimers in infected MEFs. Examination of
IRF3 binding to DNA after SINV infection suggests this step is also not
antagonized.
Synthesis of IFN-β is inhibited in SINV TR339-infected MEF cultures
The absence of detectable IFN-α/β production from alphavirus-
infected MEFs, in spite of the successful activation, nuclear trans-
location andDNAbinding of the IRF3master transcription factor, led us
to examine whether the IFN-β promoter was activated after SINV
TR339 infection of wt or TBK1-deﬁcient MEFs. Activity of the IFN-β
promoter, as well as the transcription factor-speciﬁc positive regu-
latory domains (PRDI/III) of the promoter,was examined (Figs. 3A and
B). In keeping with the results in Fig. 1, SeV infection of wt MEFs
resulted in IFN-β promoter and IRF3-speciﬁc PRDI/III activity;
however, promoter activity was abrogated in the absence of TBK1. In
contrast, SINV TR339 infection of neither wt nor TBK1-deﬁcient MEFs
resulted in IFN-β promoter or PRDI/III activity greater than detected in
mock-infected cells, measured at the level of mRNA accumulation
(data not shown) or luciferase production (Figs. 3A and B). From theTBK1−/− MEFs were mock infected or infected with each virus at an MOI of 3 and
blot for IRF3. (B) Cells were infected as in (A) and processed for fractionation as
th either IRF3 or fractionation control proteins tubulin or lamin A/C. (C) Cells were
IRF3 Western blots as described in Materials and methods. Numbers in the ﬁgure
es from virus-infected cells are presented as a ratio to mock for each cell type. (D)
scribed in Materials and methods followed by mock infection or infection with each
r VEEV structural proteins. Then the subcellular location of GFP signal was scored in
FP were co-localized. Error bars are standard deviations and some are too small to be
Fig. 3. Interferon promoter activity after SINV TR339 infection of MEFs. Control and
TBK1−/− MEFs were co-transfected with the (A) IFN-β promoter or (B) PRDI/III-
dependent ﬁreﬂy luciferase reporters and a renilla control reporter constructs as
described in Materials and methods. Approximately 18 h later, the cells were mock
infected or infected with each virus at an MOI of 3. At 12 h p.i., lysates were harvested
for dual luciferase assay. Data are presented as the ratio of relative light units (RLU)
from a control renilla luciferase-expressing plasmid to RLU from each inducible
reporter. Error bars represent standard deviations and some are too small to be seen. Fig. 4. RT-PCR for mRNAs encoding IFN induction pathway components. Control or
TBK1−/−MEFs were mock-infected or infected with each virus at an MOI of 3 followed
by harvesting of total RNA at 8 h p.i. RT-PCR for each mRNA and agarose gel separation
of products was performed as described in Materials and methods.
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production from SINV TR339-infected MEFs occurs due to arrest of
host transcription/translation of IRF3-dependent genes including the
type I IFNs, not because upstream signaling pathways are inhibited.
Ampliﬁcation of IFN-α/β induction pathway components is perturbed
in SINV TR339-infected cells
To conﬁrm that the MEFs expressed mRNA for various compo-
nents of the IFN-α/β induction pathways, we performed RT-PCR on
RNA derived from uninfected or infected wt or TBK1−/− MEFs,
evaluating the abundance of mRNAs speciﬁc for TLR3, TLR7, PKR,
MDA5, RIG-I, TBK1, IκKɛ, IRF3 and IRF7. With the exception of IRF7,
mRNAs for each gene product were present in mock-treated cells
(Fig. 4), consistent with IFN-α/β production being induced by both
RIG-I and MDA5/PKR agonists (Fig. 1 and data not shown). SeV
infection induced TBK1-dependent upregulation of mRNAs for RIG-I,
MDA5, PKR, IRF7 and TLR3 at 8 h p.i. suggestive of direct
TBK1-dependent, IRF3-mediated upregulation of these mRNAs by
the virus infection and/or the amplifying activity of signaling by
early IFN-α/β release, consistent with previous ﬁndings (Yount et al.,
2007). In contrast, no transcriptional upregulation was observed in
SINV TR339-infected cells for any of these PRRs or cell signal me-
diator genes, consistent with the demonstrated failure of these cells
to secrete IFN-α/β and/or the arrest of host macromolecular
synthesis in SINV-infected MEFs (Frolova et al., 2002). These data
indicate that, in addition to blocking the synthesis of type I IFN, wild-
type SINV infection inhibits the IRF3 and/or IFN-α/β-dependent
ampliﬁcation of proteins that allow the host cell to detect the
presence of the invading pathogen.A SINV mutant that does not inhibit host macromolecular synthesis
induces IFN-α/β after infection of MEFs, dependent upon the presence
of TBK1
The nsP2 protein of Old World alphaviruses such as SINV is a
multifunctional protein that contains protease activity required for
nonstructural protein processing, as well as RNA helicase, NTPase and
RNA triphosphatase activities important in RNA replication (Gomez
et al., 1999; Rikkonen et al., 1994; Vasiljeva et al., 2000). In addition,
several studies have implicated the nsP2 protein in the shutoff of host
cell transcription and translation (Breakwell et al., 2007; Garmashova
et al., 2006) and it has been proposed that host shutoff functions to
antagonize stress responses in infected cells, including the induction
of IFN-α/β (Frolova et al., 2002; Breakwell et al., 2007). Single amino
acid changes in nsP2 such as the glycine to proline mutation at amino
acid position 726 reduce SINV-mediated shutoff of host transcription
and translation, abrogate cytopathogenicity and promote IFN-α/β
induction (Frolova et al., 2002; Garmashova et al., 2006). Therefore,
we utilized a version of SINV TR339 that encodes this mutation to
conﬁrm the production of IFN-α/β by infected cells in the absence of
transcription/translation arrest and to identify PRRs involved in
recognition of SINV by host cells resulting in IFN-α/β production.
Furthermore, use of the mutant virus allowed quantitative measure-
ment of IFN-α/β which would be especially important if induction
was dependent upon multiple PRRs.
We ﬁrst conﬁrmed that the nsP726 gly-pro mutant of SINV TR339
(designated SINV 39nc) replicated normally and was non-cytopathic
when compared to SINV TR339. Growth curve analyses of SINV
Fig. 5. Virus replication, IFN-α/β induction and IRF3 activation after SINV 39nc
infection of MEFs. (A) Control or TBK1−/− MEFs were infected with SINV TR339
(squares) or SINV 39nc (triangles) at an MOI of 3 and supernatants were harvested at
various intervals for plaque titration of virus. (B) Control or TBK1−/− MEFs were
infected with each virus at an MOI of 3 and supernatants were collected for biological
interferon assay at the times indicated. Some of these data were published previously
(Ryman and Klimstra, 2009). (C) Control cells were mock-infected or infected with
each virus at an MOI of 3 and processed for IRF3 dimerization analysis as described in
Materials andmethods at 12 h p.i. (SeV) or 24 h p.i. (SINV 39nc). Error bars are standard
deviations and some are too small to be seen.
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defective in replication in the MEFs, although growth was somewhat
slower (Fig. 5A). Consistent with previous reports of another SINV
strain containing this mutation (Frolova et al., 2002), both gross
manifestations of cytopathic effect (CPE) examined by light micros-
copy and shutoff of host protein synthesis evaluated with radioactive
label pulse chase analysis were minimal through 36 h p.i. (data not
shown). In comparison, CPE was extensive within SINV TR339-
infected cultures by 18 h p.i. with 100% CPE occurring by 24 h p.i. and
a signiﬁcant reduction in host protein synthesis was observed by 8 h
p.i. (data not shown). We then analyzed the ability of SINV 39nc
mutant-infected MEF cultures to produce IFN-α/β. wt or TBK1-
deﬁcient MEFs were infected with SINV 39nc at an MOI of 3 and
supernatants were collected and used in biological IFN-α/β assays
(Fig. 5B). Using a GFP-expressing virus, we determined that this MOI
resulted in 100% of the cells being infected at 24 h p.i. Unlike the
wild-type SINV TR339, the non-cytopathic virus induced IFN-α/β in
wt, but not TBK1−/−, MEFs, suggesting that TBK1 is critical for
induction of IFN-α/β by SINV 39nc. Surprisingly, although progenySINV 39nc virion release could be detected within 6–12 h p.i., IFN-α/
β was detected only at later times p.i. (N30 h p.i.), a time at which
complete CPE was observed for MEFs infected at the same MOI with
SINV TR339.
We examined the dimerization of IRF3 and its translocation to
the nucleus after SINV 39nc infection of the MEFs. Altered migra-
tion of IRF3 consistent with dimerization was observed after 24
h p.i. with SINV 39nc and it appeared similar to that observed with
SeV at 12 h p.i. (Fig. 5C). In contrast with SINV TR339, dimerization
was not detected at 12 h p.i. with SINV 39nc (data not shown)
which may reﬂect the reduced replication rate of SINV 39nc (e.g.,
Fig. 5A).
The effects of IFN-α/β induction in SINV 39nc-infected ﬁbroblasts
and their dependence upon the presence of TBK1 were further
explored by semi-quantitative RT-PCR for IFN-α/β induction pathway
components (Fig. 6). At 8 h p.i., consistent with the lack of IFN-α/β
production by SINV 39nc-infected cells at this time and similar to SINV
TR339, no upregulation of mRNAs for IFN-inducible gene products
RIG-I, MDA5, PKR, IRF7 and TLR3 was observed (Fig. 6A). However,
both SeV infection and IFN-α/β treatment resulted in upregulation
within 8 h. By 24 h p.i., transcription of these mRNAs was clearly
upregulated after SINV 39nc infection of wt but not TBK1-deﬁcient
cells, while IFN-α/β treatment upregulated these mRNAs in both cell
types (Fig. 6B).
Taken together with the lack of stimulation of IFN-β promoter
activity by SINV TR339, these data suggest that wt alphavirus infection
precludes IFN-α/β induction in MEFs by blocking gene expression
events after migration of activated IRF3 to the nucleus. The mutation
in SINV 39nc overcomes this blockade most likely through failure to
arrest host macromolecular synthesis. However, it should be noted
that activation of the IFN-α/β induction pathway by the mutant virus
is evident only relatively late after infection.
PKR and MDA5, but not RIG-I, are important for detection of the non-
cytopathic SINV in MEFs
It has been established that the PRRs for RNA viruses include the
TLR3 and TLR7 and the DexD/H box helicases RIG-I and MDA5 and
that these PRRs function in a cell type-speciﬁc manner (see
Introduction). In addition to these canonical PRRs for RNA viruses,
PKR may detect poly(I:C) and activate the transcription factor NFκB
(Bonnet et al., 2000; Gil et al., 2000; Zamanian-Daryoush et al., 2000)
and has been implicated in IFN-α/β induction by West Nile virus,
another positive-sense RNA virus (Gilfoy and Mason, 2007). Previ-
ously, we described a role for PKR in IFN-α/β induction by bone
marrow-derived dendritic cells (DCs), demonstrated by a lag in IFN
production from cells lacking PKR and RNase L, but not RNase L alone
(Ryman et al., 2002). Recently, a role for PKR in IFN-α/β induction by
MEFs was shown during SFV infection (Barry et al., 2009). Therefore,
PKR may also be involved in alphavirus-induced IFN-α/β production.
We have excluded TLR3 and TLR7 from these analyses because
preliminary experiments revealed that the MEFs did not produce IFN-
α/β in response to their agonists (cell-surface poly(I:C) for TLR3 or
imiquimod for TLR7) suggesting that the TLR pathways were
nonfunctional (data not shown). To assess the role of RIG-I, MDA5
and PKR in IFN-α/β induction in the MEF model system, we ﬁrst used
siRNA technology to speciﬁcally silence expression of each mRNA,
followed by infection with SeV or SINV 39nc. Reduction in the
abundance of appropriate mRNAs was conﬁrmed by semi-quantita-
tive PCR (Fig. 7B). As expected, SeV-mediated IFN-α/β induction was
greatly reduced (pb0.001) in the presence of RIG-I siRNA; however,
no change in the level of supernatant IFN-α/β was observed in the
presence of MDA5 siRNA (pN0.05; Fig. 7A). With SINV 39nc, a
signiﬁcant (pb0.001) reduction in supernatant IFN-α/β of approxi-
mately 50% was consistently observed from MDA5 siRNA-treated
MEFs, whereas, surprisingly, knockdown of RIG-I mRNA reproducibly
Fig. 6. Effects of SINV 39nc infection upon abundance of mRNAs for interferon induction pathway components. Control or TBK1−/−MEFs were mock-infected, infected with SeV or
SINV 39nc at an MOI of 3 or treated with 1000 IU/ml of IFN-α/β followed by harvesting of total RNA at either 8 h p.i. (A) or 24 h p.i. (B). RT-PCR for each mRNA and agarose gel
separation of products was performed as described in Materials and methods.
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Finally, we made multiple attempts to reduce PKR mRNA using the
siRNA approach; however, knockdown of PKR mRNA and protein was
minimal at the time of IFN-α/β measurement after SINV 39nc
infection (N30 h p.i.) perhaps due to induction of PKR gene trans-
cription by the virus infection (Fig. 6).
To further assess the role of PKR and MDA5 in the alphavirus IFN-
α/β induction pathway, we utilized two additional strategies:
infection of MEFs deﬁcient in either PKR or MDA5 (Fig. 8) or
pharmacological inhibition of PKR (data not shown). As expected,
neither the MDA5−/− nor PKR−/− cells produced IFN-α/β after SINV
TR339 infection (data not shown), while SeV infection of either cell
type induced ∼500 IU/mL IFN-α/β, similar to wt cells. After SINV 39nc
infection, a decrease in the amount of detectable IFN-α/β was
observed in PKR-deﬁcient MEFs (125 IU/mL) when compared to wt
MEFs (1667 IU/mL); however, IFN-α/β was still produced in the
absence of PKR suggesting the presence of another PRR capable of
detecting SINV 39nc infection. Similar results were observed with
PKR/RNase L−/− MEFs (data not shown). Consistent with the siRNA
results, MDA5−/− cells produced ∼80% less IFN-α/β versus controls
after SINV 39nc infection (pb0.01).
Treatment of four independently-derived wt C57BL/6 MEF cell
lineswith the PKR inhibitor 2-aminopurine (50 µM) (Zinn et al., 1988)
had no effect upon IFN-α/β induction by SeV while it reduced SINV
39nc-mediated induction in each cell line to varying degrees.
However the reduction was signiﬁcant (pb0.05) versus a DMSO
control in only one cell line (data not shown). We also attempted to
use another commercially available PKR inhibitor (Calbiochem) butthis drug appeared to lack speciﬁcity for PKR in that, while IFN-α/β
induction by SINV 39ncwas consistently reduced in a dose-dependent
manner, early IFN-α/β induction by SeV (b12 h p.i.) was inhibited if
the drug was maintained in the cultures longer than 1 h, and even
when cells were exposed to the drug for 1 h only (as reported (Gilfoy
and Mason, 2007)), IFN-α/β produced in response to SeV was
reduced when measured after 12 h p.i.
Finally, since a number of reports have implicated activation of the
NFκB pathway in PKR-mediated IFN-α/β induction (Kumar et al.,
1994, 1997; Uetani et al., 2000), we examined the stimulation of a
transfected NFκB-dependent PRDII promoter-driven luciferase re-
porter (McWhirter et al., 2004) after infection with SeV or SINV 39nc.
In contrast to SINV TR339, which did not stimulate reporter activity
over mock-infected cells (data not shown), both SeV (consistent with
the results of others; e.g., Zhou and Perlman, 2007) and SINV 39nc
resulted in signiﬁcant promoter activity after infection (Fig. 9;
pb0.001 versus mock for both). Taken together, our results indicate
that MDA5 and PKR contribute to alphavirus IFN-α/β induction in
ﬁbroblasts; however, we cannot exclude the activity of additional
PRRs that may also detect SINV 39nc or that detection of wild-type
viruses may not be identical.
MEFs are competent for IFN-α/β induction early after alphavirus
infection
The data described above suggest that SINV and likely other
alphaviruses antagonize IFN-α/β induction in MEFs primarily
through arrest of host macromolecular synthesis. However, since
Fig. 7. siRNA-mediated knockdown of MDA5 or RIG-I. (A) Control MEFs were
transfected with siRNAs speciﬁc for cyclophilin B, RIG-I, MDA5 and a non-targeting
(negative) control or treated with transfection reagent (DF3). At 48 h post-treatment,
cells were infected with SeV or SINV 39nc at an MOI of 3 and supernatants were
collected for biological IFN-α/β assay at 12 h p.i. (SeV; open bars) or 48 h p.i. (SINV
39nc; solid bars). Results for other treatments are normalized to the cyclophilin B siRNA
treatment which is set to 100%. Error bars are standard deviations. (B) Semi-
quantitative RT-PCR for mRNA of the target genes encoding cyclophilin B, RIG-I,
MDA5 or β-actin which was used as a loading control. Samples are duplicates of the
treatments described above. At 96 h post-siRNA transfection, total RNA was harvested
from mock-infected cells and processed for RT-PCR and agarose gel separation as
described in Materials and methods.
Fig. 8. Interferon induction after infection of MDA5−/− or PKR−/−MEFs. Control MEFs
or MDA5-deﬁcient or PKR-deﬁcient MEFs were infected with each virus at an MOI of 3.
Supernatants were harvested at 24 h p.i. (SeV) or 48 h p.i. (SINV 39nc) for biological
IFN-α/β assay. Each bar represents the average of triplicate samples. Error bars are
standard deviations and some are too small to be seen.
Fig. 9. Activation of the NFκB pathway after SINV 39nc infection Wild-type C57BL/6
MEFs were co-transfected with PRDII-dependent ﬁreﬂy luciferase and constitutive
renilla reporters. At 24 h post-transfection, cells were mock-infected or infected
with either SeV or SINV 39nc and lysates were collected for a dual luciferase assay at
12 h p.i. (SeV) or 48 h p.i. (mock and SINV 39nc). Data are presented as the ratio of
relative light units (RLU) from a control renilla luciferase-expressing plasmid to RLU
from each inducible reporter. Error bars are standard deviations and some are too
small to be seen.
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with SeV-infected cells and IFN-α/β production is not observed at
any time p.i. with wt SINV, we sought to determine if infected cells
were competent for IFN-α/β production early after infection prior to
the time at which shutoff occurred. Failure of cells to produce IFN-α/
β at early times would imply additional mechanisms of antagonism.
Therefore, we infected wt MEFs with SINV TR339 or SINV 39nc and
co-treated with RIG-I or PKR/MDA5 agonists, SeV or poly(I:C),
respectively (Kato et al., 2005; Yoneyama et al., 2004; Gitlin et al.,
2006; Diebold et al., 2003), either simultaneously or at 6 h p.i. with
SINV. Supernatants were collected and used in biological IFN assays
to compare the amount of IFN-α/β produced by SINV TR339-infected
cells to mock-infected cells (Fig. 10). Simultaneous infection of MEFs
with SINV TR339 and SeV resulted in ∼20% reduction in IFN-α/β
production compared to mock/SeV co-treatment. When SeV infec-
tion occurred 6 h p.i. with wild-type SINV, IFN-α/β production was
reduced by ∼80% when compared to mock infected, although IFN-α/β was still reproducibly detected (Fig. 10A). After poly(I:C)
transfection of SINV TR339-infected cells, IFN-α/β induction was
attenuated similar to that for SeV when delivered simultaneously
and slightly greater than for SeV (2-fold) when the poly(I:C) was
given 6 h p.i. with SINV TR339. Therefore, provided that PAMPs are
detected by host PRRs, both the RIG-I and MDA5/PKR induction
pathways are functional early after wt SINV infection in a time-frame
in which the cells can produce IFN-α/β. We also tested if the
reduction in SeV-initiated IFN induction observed with wild-type
SINV TR339 was associated with the ability of this virus to shut off
host processes. Accordingly, treatment of SINV 39nc-infected cells
with SeV or poly(I:C), either simultaneous with or 6 h p.i., did not
result in any reduction of IFN-α/β produced when compared to
mock-treated cells (Fig. 10B). From these data we infer that the PRRs
that detect SINV in the MEFs do not do so until relatively late in
infection, by which time arrest of host macromolecular synthesis
prevents the production of IFN-α/β.
Discussion
We initiated these studies to examine the PRRs responsible for
IFN-α/β induction after alphavirus infection of cultured cells choosing
the MEF model system due to the abundance of genetically-modiﬁed
mice with deletions of components of the innate immune response
and the availability of MEF cell lines derived from them. However,
Fig. 10. Effects of SINV infection upon IFN-α/β induction by IFN pathway agonists. WT
MEFs were infected with SINV TR339 (A) or SINV 39nc (B) and treated with SeV
(infection) or poly(I:C) (transfection) either simultaneously with (open bars) or 6
h after (black bars) SINV infection as described in Materials and methods. IFN-α/β
levels were measured at 24 h post-SINV infection and are presented as a percentage of
those in control wells that were treated with SeV or poly(I:C) but not infected with
SINV. Interferon was measured with either the IFN-α/β bioassay or an IFN-β ELISA
(PBL). Error bars are standard deviations and some are too small to be seen.
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SINV, VEEV, EEEV and CHIKV failed to secrete signiﬁcant IFN-α/β.
This was in contrast to the well-studied negative-sense virus SeV
which, we and others have observed, induces high levels of IFN-α/β in
a TBK1-dependent manner by 8–12 h p.i. (e.g., McWhirter et al.,
2004). With SINV, we demonstrated that this phenotype reﬂected
minimal upregulation of transcription or protein production from
genes driven by the IFN-β promoter implying an antagonism at, or
upstream of, transcription of the IFN gene mRNAs, although other
activities that alter mRNA abundance may also be involved. Increased
IRF3 dimerization, nuclear translocation and DNA-binding activity
could be demonstrated in the MEFs after SINV TR339 infection.
Similarly, but perhaps more efﬁciently than SINV TR339, VEEV caused
an increase of IRF3 nuclear translocation after infection. In contrast to
SINV TR339, the SINV 39nc virus which fails to rapidly arrest host
macromolecular synthesis after infection induced TBK1-dependent
IRF3 activation and the release of detectable IFN-α/β into super-
natants. However, in comparison with SeV this was observed later
after infection (30 h p.i.). Examination of the PRRs responsible for IFN-
α/β induction by the non-cytopathic virus implicated PKR andMDA5,
but not RIG-I, as host detectors of replicative intermediates in the
MEFs.
Our previous results revealed a role for PKR in the efﬁciency of
induction of IFN-α/β early after infection of bone marrow-derived
conventional DC cultures (Ryman et al., 2002). The current results
conﬁrm these data and suggest that PKRmay also play a role in IFN-α/
β induction in MEFs. Several recent publications have implicated PKR
in IFN-α/β induction by positive-sense RNA viruses and/or poly(I:C)
(Gilfoy and Mason, 2007; Diebold et al., 2003; Ryman et al., 2002;
Balachandran et al., 2000; Carpentier et al., 2007; Yang et al., 1995;
Kalali et al., 2008). The primary mechanism through which PKR is
thought to stimulate IFN-α/β production is by inducing phosphory-lation of IκB and activation of the NFκB transcription pathway (Kumar
et al., 1994; Kumar et al., 1997; Uetani et al., 2000), although evidence
has also been presented that PKR is involved in signaling downstream
of TLRs (Oganesyan et al., 2006). In our studies, IFN-α/β induction by
SINV 39nc was absolutely dependent upon the presence of TBK1 and
appeared to be associated with activation of the NFκB-dependent
PRDII promoters.
Our data also indicate that MDA5 is partially responsible for IFN-
α/β induction by SINV 39nc in MEF cultures. Recognition of alpha-
virus infection by MDA5 is logical in that dsRNA is a strong activator
of this RNA helicase (Gitlin et al., 2006; Kato et al., 2006) and high
levels of dsRNA are produced as a consequence of alphavirus
replication (Grifﬁn, 2001). The fact that inhibition or deletion of
PKR also reduced IFN-α/β induction may suggest that the MDA5 and
PKR induction pathways or expression levels are interdependent.
PKR associates with TRAF3, an essential component of the intracel-
lular IFN-α/β induction pathway and binding partner of TBK1
(Oganesyan et al., 2006), perhaps accounting for this phenotype. This
also may explain reports in the literature in which either MDA5 or
PKR was independently shown to be essential for intracellular
detection of poly(I:C) in cells of myeloid lineage (Kato et al., 2006;
Gitlin et al., 2006; Diebold et al., 2003).
Interestingly, reduction of RIG-I mRNA abundance actually
increased IFN-α/β induction by SINV 39nc which may be secondary
to increased virus replication in the cultures. Increased IFN-α/β
induction was also observed from SINV 39nc-infected wt MEFs
expressing a tetracycline-inducible dominant-negative RIG-I mutant
(data not shown). These results suggest several interpretations with
respect to the role of RIG-I: (i) this PRR exerts a direct antiviral activity
versus SINV; (ii) constitutive RIG-I activity is responsible for induction
of other antiviral activities that suppress SINV replication in cells; or
(iii) RIG-I is a minor PRR for SINV and induces amounts of IFN-α/β
that are below the limit of detection of our assays but, nonetheless,
inhibit SINV replication. In each case, it is possible that when RIG-I
activity is suppressed by siRNA-mediated knockdown or dominant-
negative mutant expression, SINV replication and signaling through
other PRRs is increased. Overall, our data implicate the involvement of
MDA5 and PKR in IFN induction by alphaviruses. However other PRRs,
for example the LGP2 helicase (Venkataraman et al., 2007), may also
be involved.
In contrast with our results, Gorchakov et al. (2004) indicated
that IFN-α/β induction was only slightly reduced in supernatants of
PKR−/− cell cultures infected with a nsP2 726G mutant SINV
compared with Swiss 3t3 MEFs used as controls; however, the
magnitude of induction was not shown and wt MEFs analogous to the
PKR-deﬁcient cells were not tested. It is possible that the biological
assay employed by these investigators was more sensitive than our
assay or there might be differences in IFN-α/β induction between the
SINV Toto1101 strain used by that group as a backbone for
mutagenesis and the SINV TR339 strain we have used. Occasionally
we detected higher IFN-α/β induction in the PKR−/− cell cultures;
however, this was found primarily when the cells were very conﬂuent
(data not shown). It is possible that these conditions affected the
expression level or activity of other compensatory PRRs.
Studies with SFV support our results that IRF3 translocation is not
inhibited after infection in cells that fail to induce IFN-α/β
(Breakwell et al., 2007). Interestingly, studies examining the
activities of alphavirus proteins that promote host shutoff have
indicated that the capsid protein of New World alphaviruses (but
not Old World alphaviruses) may arrest host cell transcription by
disruption of nuclear translocation of some proteins (Atasheva et al.,
2008). A similar transcription inhibitory function has been attributed
to the nsP2 protein of Old World alphaviruses (but not New World
alphaviruses); however, the mechanism through which nsP2
promotes shutoff remains uncharacterized (Garmashova et al.,
2007; Breakwell et al., 2007). Our data suggest that type I IFN
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alphaviruses by interference with accumulation of IFN-α/β gene
mRNAs. However, we do not observe IFN-α/β production by MEFs
infected with non-propagative VEEV replicon particles that do not
express the capsid protein (data not shown), suggesting that
another host process is also blocked (e.g., translation; Yin et al.,
2009).
The results we describe may indicate a mechanism of antagonism
of the IFN-α/β response of MEFs by alphaviruses in addition to virus-
mediated host macromolecular shutoff as it appears that MEFs fail to
detect SINV replicative intermediates early after infection. In our
system, production of IFN-α/β is not detected in response to SINV
TR339 infection prior to the time at which arrest of host transcrip-
tion/translation occurs although co-treatment with RIG-I or PKR/
MDA5 agonists during this time induces the release of IFN-α/β from
SINV-infected cells. With the shutoff-defective SINV 39nc, detectable
IFN-α/β is induced only N30 h p.i., a time at which virus titer has
increased multiple orders of magnitude over input and replicative
intermediates must be abundant. Therefore, it appears that virus
replicative intermediates remain hidden from cellular PRRs during
the earlier stages of infection. We (Ryman and Klimstra, 2009) and
others (Gorchakov et al., 2008) have suggested this hypothesis
previously for SINV and a similar mechanism has also been proposed
to explain the failure of mouse hepatitis virus to induce an IFN-α/β
response in MEFs (Zhou and Perlman, 2007) and delayed induction
by West Nile virus infection (Fredericksen et al., 2004). However the
observation that SINV 39nc replication was delayed versus SINV
TR339 may suggest that production or accumulation of replicative
intermediates that trigger IFN-α/β induction may simply be delayed
such that PRRs are triggered only by 30 h p.i. with the non-cytopathic
virus. Also, as yet uncharacterized differences between non-cyto-
pathic and cytopathic alphaviruses must be considered. Understand-
ing of the particular alphavirus replicative intermediates that
stimulate PRRs and the timing of their production will be required
to clarify this issue.
Finally, any discussion of antagonism or evasion of host innate
immunity should be considered in light of the documented and
expected responses of intact vertebrate hosts to infection with
alphaviruses. Upon subcutaneous inoculation, arthropod-borne
viruses such as alphaviruses interact with cells in interstitial tissue
spaces such as DCs and macrophages and virions are also likely
introduced into the bloodstream resulting in infection of similar cells
in the spleen and elsewhere (Ryman et al., 2000; MacDonald and
Johnston, 2000). Subsequently, depending upon the virus, pancreatic
cells, osteoblasts, skeletal muscle, neurons and other cells of the
central nervous system are targeted (Grifﬁn, 2001). In contrast with
the failure of all alphaviruses tested to induce substantial IFN-α/β in
MEF cultures, multiple studies have shown robust IFN-α/β
responses after infection of animals with VEEV and SINV (Klimstra
et al., 1999; Ryman et al., 2000; Grifﬁn, 2001; Charles et al., 2001;
Gardner et al., 2008) and our global transcription analysis of SINV-
infected DC cultures indicated upregulation of the transcription of
IFN-α/β and other innate response genes followed by accumulation
of high levels of IFN-α/β in supernatants (Ryman et al., 2005; Ryman
et al., 2002). Conversely, we have found that primary murine
osteoblast and cortical neuron cultures, like MEFs, fail to produce
substantial IFN-α/β after infection with SINV, VEEV, EEEV or CHIKV
(C.W. Burke, C.L. Gardner, J. Yin, K.D. Ryman and W.B. Klimstra,
unpublished observations; Yin et al., 2009). Therefore, the capacity
to respond to infection by production of antiviral cytokines may be
highly dependent upon the characteristics of interaction of the virus
with a particular cell type, with MEFs more closely resembling other
non-myeloid cells. These observations underscore the importance of
examining the inductive phase of the innate immune response in
cells and tissues relevant to virus replication and disease pathogen-
esis in vivo.Materials and methods
Cell lines
TBK1−/− (Perry et al., 2004), PKR−/− (Yang et al., 1995),MDA5−/−
(Gitlin et al., 2006), PKR/RNaseL−/− (Zhou et al., 1999) or wild-type
C57BL/6 mouse embryonic ﬁbroblasts (MEFs) and 293 human kidney
cells were maintained in ﬁltered Dulbecco's modiﬁed Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum (Gibco), 0.29 mg
of L-glutamine/ml (Mediatech), 1% nonessential amino acids (Media-
tech), and 1× β-mercaptoethanol (Gibco). L929 and Baby Hamster
Kidney (BHK-21) cells (ATCC) were maintained in alpha minimal
essential medium (AMEM) supplemented with 10% donor calf serum
(Gibco), 2.9 mg of tryptose phosphate/ml, 0.29 mg of L-glutamine/ml
and 100 U of penicillin/ml and 0.05 mg of streptomycin/ml
(Mediatech). All cells were cultured at 37 °C and 5% CO2.
Viruses and antibodies
The SINV TR339 strain of SINV has been described (Klimstra et al.,
1998). The FL93-939 cDNA clone of North American EEEV, ZPC738
cDNA clone of VEEV (a gift from Dr. Scott Weaver, UTMB, Galveston)
and the La Reunion cDNA clone of CHIKV (a gift from Dr. Stephen
Higgs, UTMB, Galveston) have been described (Aguilar et al., 2007;
Anishchenko et al., 2004; Tsetsarkin et al., 2006). SeV was obtained
from ATCC. The SINV TR339-nsP2 726-G virus (designated SINV 39nc)
was constructed by overlap PCR using a mutagenic primer that
introduced a C–G mutation at nucleotides 3855 and 3856 of the SINV
nsP2 gene resulting in a proline-glycine coding change previously
shown to greatly reduce the cytopathogenicity and transcription/
translation shutoff of the Toto1101 strain of SINV (Frolova et al.,
2002).
Antisera reactive with PKR, IRF3, tubulin and lamin A/C were
obtained from Santa Cruz Biotechnology and an additional antiserum
reactive with IRF3 was obtained from Zymed.
Virus stocks, infections and drug treatments
To prepare the alphavirus stocks, the cDNA clone was linearized
and used in an in vitro transcription reaction. The resulting RNA was
electroporated into BHK-21 cells (two pulses at 0.22 kV, 1.0 mF of
capacitance). Virus containing culture supernatants were collected 24
h post-electroporation, clariﬁed by centrifugation and used as viral
stocks. Alphavirus stocks were titered by standard plaque assay on
BHK-21 cells or on each of the corresponding cell types and expressed
as PFU per ml. Sendai virus Cantell strain (ATCC) titer was calculated
by plating serial dilutions on BHK-21 cells and visualizing the
infectious dose that caused 50% CPE. Encephalomyocarditis virus
stocks were ampliﬁed in and titered on BHK cells. Unless otherwise
stated MEFs were infected at an MOI of 3 with alphaviruses or 3
TCID50 of SeV for 1 h followed by two washes with Dulbecco's
phosphate-buffered saline with calcium and magnesium (PBS;
Mediatech) supplemented with 1% donor calf serum followed by
medium replacement. For co-treatment experiments, cells were
either simultaneously infected with SeV and SINV or simultaneously
infected with SINV and transfected with poly(I:C) (75 μg/ml;
DharmaFECT 4 reagent) or infected with SINV and infected/
transfected with SeV or poly (I:C) 6 h after SINV.
Cells were treated with several doses of a PKR inhibitor
(Calbiochem #527450; ranging from 1 to 100 μM) prior to infection
with the drug either replaced or not replaced after infection
depending upon the experiment. Cells were treated with 50 μM 2-
aminopurine (dimethyl sulfoxide [DMSO] diluent) for 1 h prior to
infection. Cells were treated with the TLR7 agonist imiquimod or TLR3
agonist poly(I:C) (75 μg/ml) (Invivogen) and IFN induction was
measured at 12 h post-treatment. Poly(I:C) was also transfected into
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Interferon alpha/beta bioassay
The concentration of biologically active IFN-α/βwas measured by
standard IFN assay on L929 murine ﬁbroblast cells with encephalo-
myocarditis virus (EMCV) as the challenge virus (described previously
(Trgovcich et al., 1996)). Brieﬂy, L929 cells were seeded in 96-well
plates at a concentration of 3×104 per well and incubated for 24 h.
Experimental samples were adjusted to a volume of 250 μl and
acidiﬁed to pH 2 with 1N HCl. Acidiﬁed samples were incubated 24
h at 4 °C. The samples were returned to pH 7with 2N NaOH and 100 μl
of each were put into the ﬁrst well of the 96-well plates in duplicate.
The samples were two-fold serially diluted down the length of the
plate and the plates were incubated 24 h at 37 °C. Commercially
available IFN-α/β (Access Biomedical) of a known concentration was
used on each plate to serve as a standard and was treated in the same
manner as the samples. EMCV was added to all wells and incubated
for 24 h at 37 °C and then cells were stained with crystal violet. The
end point, deﬁned as the amount of IFN-α/β necessary to protect 50%
of the indicator cells from EMCV CPE, was then used to calculate the
IFN-α/β concentration by comparing the experimental samples to the
IFN-α/β standard.
Reporter transfection
Lipofectamine 2000 (Invitrogen) or DharmaFECT 3 (Dharmacon)
reagent was used to transfect cells 1 day post-plating following the
manufacturer's protocol. The following concentrations of DNA were
used unless otherwise stated: pβLUX, 0.5 μg; pRL-SV40, 0.02 μg; and
PRDI/III and PRDII, 0.5 μg. Transfected cells were incubated at 37 °C
with 5% CO2 for 18 h prior to infection. The IFN-β promoter, pβLUX,
and control, pRL-SV40, plasmids were gifts from Dr. Barbara Sherry,
North Carolina State University (Noah et al., 1999) and the PRDI/III
and PRDII plasmids were gifts from Dr. Tom Maniatis, Harvard
University (McWhirter et al., 2004).
RT-PCR detecting mRNA for IFN induction pathway components
Total cellular RNA was harvested from MEFs using the RNeasy kit
(Qiagen). Random hexamers were used for cDNA synthesis using
Superscript III reverse transcriptase and equal volumes of total
cellular RNA. Equal concentrations of cDNA were then used in PCR
reactions using primers speciﬁc to each target mRNA. Amplicons were
then separated on agarose gels followed by ethidium bromide
staining. Control reactions in which no reverse transcriptase was
added indicated that ampliﬁed products were derived from mRNA.
Dual luciferase assay
Dual luciferase assays were performed following the manufac-
turer's protocol (Promega). Brieﬂy, the surface of the cells waswashed
twice with PBS. Passive lysis buffer was added and the plates were
incubated at room temperature on an orbital shaker for 15 min.
Homogeneous lysates were made by scraping the wells with a rubber
policeman, collected into 1.5 ml tubes and then stored at −80 °C.
Measurements were made using the POLARstar OPTIMA (BMG
LABTECH) and results were normalized by dividing ﬁreﬂy luciferase
activity by renilla luciferase activity.
Oligonucleotide pull-down assay
ONPD assays were performed similarly to methods previously
described (Melchjorsen et al., 2005). Brieﬂy, virus treated cells were
washed one time with PBS, collected and lysed in a buffer containing1M HEPES, pH 7.4, 1.5 M KCl, 1 M DTT, 50% glycerol, 0.5 M EDTA,
250 mM EGTA, 10% Triton X-100, 100 mM Na3VO4 and protease
inhibitors (Roche). Lysates were incubated sequentially with neu-
travidin-agarose beads coupled to 5′-biotinylated oligonucleotides of
the IRF3 binding sites in the IFN-β promoter (Siren et al., 2005).
Agarose bound proteins were disassociated by boiling in SDS sample
buffer for 7 min and equal amounts of protein were run on 10% SDS–
PAGE gels. Proteins were transferred to PVDF membrane using the
Trans-Blot electrophoretic transfer system (BioRad) at 0.9 A for 2 h.
Membranes were blocked in TBST containing 5% milk overnight at
4 °C. The following day, IRF3 was detected using the Zymed anti-IRF3
antibody (1:1000) in TBST containing 1% milk. IRF3 binding was
calculated by densitometric analysis of ﬁlms using the VersaDoc
instrument and software (BioRad).
Native PAGE and Western blot
Native PAGE analysis was performed following a previously
described method (Iwamura et al., 2001). Cells were lysed using a
buffer containing 50 mM Tris–Cl, pH 8.0, 1% NP40, 150 mM NaCl,
phosphatase inhibitor cocktail (Sigma) and complete protease
inhibitor (Roche). Collected cells were vortexed and the insoluble
fraction was removed by centrifugation (15,000 rpm, 10 min). Precast
acrylamide gels (4–15%; BioRad) were pre-run at 4 °C 40 mA for
30 min with 0.2% DOC in cathode chamber buffer. Protein (50 μg) in
2× sample buffer without SDS and β-ME was loaded and run at 4 °C.
Proteins were transferred to PVDF membrane using the mini Trans-
Blot electrophoretic transfer system (BioRad). Membranes were
blocked in TBST containing 5% milk overnight at 4 °C. IRF3 was
detected using the Zymed anti-IRF3 antibody (1:1000) in TBST
containing 1% milk.
siRNA transfection and gene knockdown conﬁrmation
PKR (Cat# L-040807-00-0005), MDA5 (Cat# L-048303-00-0005),
RIG-I (Cat# L-065328-00-0005), positive control cyclophilin B (Cat#
D-001820-20-05) and negative control non-targeting (Cat# D-
001810-10-05) synthetic siRNA were purchased from Dharmacon
RNA Technologies. Transfection of siRNAs was carried out following
the manufacturer's suggested protocol. Brieﬂy, MEF/3t3 cells were
plated into 24-well dishes 18–24 h prior to transfection. siRNA
(100 nM) was transfected into cells using DharmaFECT 3 (DF3)
transfection reagent 48 h prior to mock, SeV or non-cytopathic SINV
infection. Supernatants were collected 24 and 48 h post-infection and
used in biological IFN assays. RNA was collected from mock-infected
cells at 48 h post-infection using the RNeasy Kit (Qiagen) and used to
conﬁrm knockdown of gene expression by RT-PCR (methods
explained by Zhang et al., 2007).
Cell fractionation
Mock or virus-infected cells were trypsinized, collected and
washed with PBS. Cells were then washed with hypotonic buffer
(10 mMHEPES, pH 7.6, 1.5 mMMgCl2, 10 mM KCl) and split to collect
a total cell lysate and a separated lysate. Cells used to collect a total cell
lysate were pelleted, resuspended in RIPA buffer and incubated on ice
for 20 min. After incubation the total cell lysate was centrifuged to
pellet cellular debris and the supernatant was collected. Cells used to
collect cytoplasmic and nuclear fractions were pelleted, resuspended
in 1mL hypotonic buffer and incubated for 90min on ice. After 60min
of incubation, 0.5% NP-40 was added to the cells in hypotonic buffer.
At the end of the incubation, cells were disrupted using 30 strokes of a
Dounce homogenizer then spun at 2800 × g for 5 min to pellet the
nuclei. The supernatant was removed and kept as the cytoplasmic
fraction. The pelleted nuclei were resuspended in 1mL of nuclei buffer
(250 mM sucrose, 5 mM MgCl2, 25 mM KCl, 20 mM Tricine–NaOH,
131C.W. Burke et al. / Virology 395 (2009) 121–132pH7.8) and then layered over an Optiprep Discontinuous gradient
(35%, 30% and 25%). Nuclei were then centrifuged for 30 min at
10,000 × g at 4 °C. Clean nuclei were collected from the 30%/35%
interface and pelleted. Nuclei were lysed using RIPA buffer as des-
cribed above. Equal protein concentrations of total, nuclear and
cytoplasmic fractions were loaded, and lysates were separated on
SDS–PAGE gels and subjected to Western blot to detect IRF3 and
nucleus-associated proteins lamin A/C and tubulin.
Fluorescence microscopy and antibody staining of cells
An IRF3/GFP fusion plasmid (a gift from Dr. Adolfo Garcia-Sastre,
Mount Sinai School of Medicine) (Mibayashi et al., 2007) was
transfected into MEF/3t3 cells 18 h prior to infection. Cells were
mock-infected or infected with SINV TR339, VEEV or SeV at a MOI of
10 and GFP translocation was monitored using a Nikon inverted
ﬂuorescence microscope. At 16 h post-infection, cells were stained
with virus-speciﬁc antisera. For cell expressing virus antigen and GFP,
the percentage of cells counted with GFP in the nucleus versus
cytoplasm were calculated for 50 cells at each sampling time.
Statistical analysis
Statistical signiﬁcance was determined using a two-tailed Stu-
dent's t test with two sample equal variance.
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